.Merck & Co.'s long-running attempt to land a hit on small tissue bronchi cancer (SCLC) has acqui...
.Some clients with non-small cell bronchi cancer (NSCLC) have mutations in a genetics called human s...
.MBX has actually expanded strategies to consume over $136 million coming from its own IPO as the bi...
.Relay Therapeutics has actually beaten its survival target in a first-in-human bust cancer research...
.AstraZeneca has utilized expert system to formulate an unique biomarker for its own Daiichi Sankyo-...
.AstraZeneca execs mention they are actually "not worried" that the failing of tozorakimab in a peri...
.Welcome to this week's Chutes & Ladders, our roundup of substantial leadership hirings, firings ...
.After disclosing programs to strike the U.S. public markets less than a month earlier, Zenas Biopha...
.Psyence Biomedical is spending $500,000 in allotments to get fellow psilocybin-based biotech Clairv...
.5 months after validating Electrical Therapeutics' Pivya as the first brand-new treatment for easy ...